Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy
about
Gene therapy for the treatment of heart failure: promise postponedVEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.VEGF-B promotes recovery of corneal innervations and trophic functions in diabetic mice.Cardiovascular Gene Therapy: Past, Present, and Future.Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease.Current Methods in Cardiac Gene Therapy: Overview.Cardiac gene therapy with adeno-associated virus-based vectors.Use of Adeno-Associated Virus Vector for Cardiac Gene Delivery in Large-Animal Surgical Models of Heart Failure.Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9.Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.Long-term Intake of Pasta Containing Barley (1-3)Beta-D-Glucan Increases Neovascularization-mediated Cardioprotection through Endothelial Upregulation of Vascular Endothelial Growth Factor and Parkin.Gene Therapy in Heart Failure.Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.Clinical management of dilated cardiomyopathy: current knowledge and future perspectives.Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.MicroRNA-30c suppresses the pro-fibrogenic effects of cardiac fibroblasts induced by TGF-β1 and prevents atrial fibrosis by targeting TGFβRII.Treatment with placental growth factor attenuates myocardial ischemia/reperfusion injury
P2860
Q36953151-D7914314-C5D0-4FE0-8ED5-20731543FC73Q37469455-02E08D37-00B8-4E84-B4D8-F66B0B3D511AQ37587659-8491387F-1443-40A6-9FDE-234D99B5A7CFQ38733395-DB4C6B89-3A58-4FBF-80B1-81958D86E286Q38773475-5881D744-9A8F-4E0F-9150-881F44B7F921Q38788217-FD3503FE-184A-40B5-AA54-D81C53D6F44AQ39124456-9DA40459-5EE9-4B84-A786-83F761F6FB5AQ39447181-84D0ABDF-A97C-407F-BE9C-13D7EE528E1EQ40445316-E3CB19DD-EA1B-4FDE-AB2D-9ED3BE0DE249Q41150386-C2ABCE1A-EF8D-4A31-AA48-4CA8E0693769Q42677423-79F138D2-4BFD-465D-981D-5A8CA5F444BBQ45861410-FC8772B6-52BF-4302-B60B-B011C3DCDB97Q47215993-31792711-D003-410D-A913-4EAF8ED592F7Q48308293-45656984-4DB1-467E-AA6B-20B8E9E7ABA3Q51095061-0B03E775-0EEA-4D20-A4E2-6C67B517EC05Q51760757-6E2D3DC4-189C-4D83-B2A8-9FB0C2F80A7CQ52658507-0B38682F-3B13-43A0-B719-5C4F891F83C2Q58744453-A40D3921-43DC-42D7-A098-59A6FAF51FCB
P2860
Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy
@ast
Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy
@en
type
label
Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy
@ast
Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy
@en
prefLabel
Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy
@ast
Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy
@en
P2093
P2860
P1476
Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy
@en
P2093
Abdelkarim Sabri
Anna M Kulczycki
Axel Linke
Fabio A Recchia
Farah Shaikh
Felix Woitek
Harinder Singh
Isabel Ottiger
Jeffery C Powers
Lorena Zentilin
P2860
P304
P356
10.1016/J.JACC.2015.04.071
P407
P50
P577
2015-07-01T00:00:00Z